PharmStars

AKKURE is a patient-centric digital platform which uses AI to match patients’ data with the most relevant clinical trials. 80% of trials struggle to meet enrolment deadlines. AKKURE’s platform boosts enrolment and the chances of a successful trial with a more precise telemedicine network which personalizes patient access and rewards those patients for sharing their data.

Triomics is a generative AI-powered platform focused on enhancing oncology research and clinical trial operations. By streamlining processes such as patient recruitment and data collection, the company aims to accelerate trial enrollment and improve quality assurance in healthcare. Its advanced AI technology, which is adept at understanding health records and medical terminology, serves as a foundation for its services. Triomics targets operational inefficiencies common in clinical research, thereby enabling pharmaceutical companies and contract research organizations to conduct more efficient and cost-effective clinical trials. The platform ultimately seeks to enhance the overall effectiveness of oncology care and research.

Panacea-ml develops a data‑driven, explainable AI SaaS platform that optimizes clinical trial design. By analyzing historical trial data and millions of real‑world patient records, the platform identifies patient profiles that maximize therapeutic efficacy, reduce safety risks, and improve participant retention. It shortens cohort sizes, uncovers marker‑endpoint relationships, surrogate markers, and causal links beyond simple correlations. The solution is disease‑agnostic and supports a wide range of therapeutic areas, including rare diseases and early‑stage development. It delivers precise sub‑population profiles, refined patient selection criteria, and informed go/no‑go decisions for each development phase, accelerating drug development and shortening time to market.

OmicsChart is a technology company specializing in a data and biomarker discovery platform for cancer research. It aims to streamline precision oncology data sharing, fostering collaboration and accelerating clinical research. The platform unifies disparate cancer data, enabling secure, instantaneous patient data sharing and facilitating the scalable application of machine learning methods on real-world data. This ultimately expedites the journey from discovery to effective treatments, potentially saving years in the research process.

Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.

Patientory is a digital health data platform that enables individuals to store and manage personal medical records and health information, empowering patients to control their data. The platform securely manages records, offers AI-driven health coaching, tracks wellness metrics, connects users to clinical trials and affordable medications, and rewards healthy behaviors. It facilitates connections between patients and healthcare providers to support care coordination. Founded in 2015 and based in Atlanta, the company aims to streamline access to health information and enable patients to benefit from their data.

Saventic Health is a med-tech company focused on enhancing the diagnosis of rare diseases through an AI-powered clinical decision support system. The company has developed a platform that utilizes patient medical records to facilitate early diagnosis. By integrating medical data via API policies, Saventic Health analyzes this information with AI algorithms and delivers actionable feedback directly to healthcare providers. This approach not only aims to reduce the costs associated with diagnosis and patient treatment but also seeks to improve the overall effectiveness of medical interventions. Through its innovative solutions, Saventic Health addresses significant challenges in the timely and accurate identification of rare diseases.

JOGO Health is a virtual care company that specializes in digital therapeutics aimed at treating pain, neuromuscular conditions, and pelvic floor disorders. Utilizing clinically proven digital interventions, the company develops an AI-driven mobile app paired with wearable sensors that deliver tailored treatment protocols. These offerings include games and exercises designed for muscle relaxation, movement coordination, and neuromuscular reeducation, all leveraging the brain's neuroplasticity. By enhancing patient adherence to rehabilitation programs, JOGO Health enables healthcare providers to achieve improved health outcomes for conditions such as chronic pain, stroke recovery, and pelvic health issues.

Picture Health develops artificial‑intelligence tools that convert routine clinical imaging into detailed data sets, enabling oncologists to gain deeper insights into cancer diagnosis, prognosis, treatment selection, and tumor monitoring. By extracting information from every pixel, the company enhances the value of existing imaging studies and supports more precise clinical decision‑making. Picture Health collaborates with academic institutions and biopharmaceutical companies to advance oncology research and innovation.

Medra AI automates repetitive wetlab tasks so scientists can collect data and run the experiments needed to make scientific discoveries

KEEP Labs develops a smart medication storage system designed to enhance medication adherence and safety for patients, particularly vulnerable family members. Recognized as one of TIME's Best Inventions of 2020 and a CES Innovation Award winner, the platform is HIPAA compliant and focuses on protecting users from inadvertently accessing medications. By passively capturing patient behavior data in the home, KEEP Labs enables real-time interventions and insights. Its platform supports life science organizations, pharmacies, and clinicians by providing valuable data that helps identify and triage individuals based on their real-world medication utilization. Through this innovative approach, KEEP Labs aims to improve patient care and ensure better management of specialty dosage forms.

PayRx is a healthcare analytics and financial solutions provider that specializes in advanced therapies and medicines. The company has developed an innovative repository and analytics system that facilitates access to costly but potentially curative treatments for patients. By offering on-demand risk coverage solutions, PayRx enables self-insured employers and healthcare payers to manage the financial risks associated with high-cost therapies. Through its comprehensive services, PayRx aims to improve accessibility to essential healthcare solutions while supporting the financial stability of its clients.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Ampersand Health is focused on developing digital therapeutics for individuals with long-term inflammatory conditions. Based in London and incorporated in 2014, the company offers a comprehensive digital platform that includes the Ampersand Healthsuite, a management tool designed for patients, and Healthsuite for Clinicians, which supports clinician-led, patient-centered self-management. The platform utilizes behavioral science to deliver personalized therapy, featuring expert-led courses, self-management tracking, and clinical messaging. Ampersand Health aims to enhance patients' mental health and quality of life while also providing significant cost savings for healthcare providers by reducing overall healthcare utilization.

Pharmesol is a clinical services company that develops a platform to automate follow-up care for medications. The platform uses artificial intelligence to automate calls and messages, streamlining communication among patients, providers, and payers, and supports data management with recorded documentation. This enables patients and doctors to receive personalized support around the clock.

ModoScript is a developer of innovative digital healthcare solutions focused on enhancing remote treatment monitoring and big data analytics for high-cost specialty pharmaceuticals, particularly Oral Oncolytics. The company aims to improve the efficiency of medication and treatment protocols, ultimately leading to better patient outcomes in managing chronic diseases like cancer. By leveraging a customizable data analytics model, ModoScript provides pharmaceutical companies, health insurance providers, and medical practices with tools to assess treatment progress and support direct-to-patient clinical trials from home. The company collaborates with mail-order specialty pharmacies and in-office medically integrated pharmacies to facilitate remote treatment delivery. ModoScript is dedicated to ensuring that patients receive high-quality care regardless of their race, condition, or socioeconomic status, striving to make their solutions accessible at no cost to patients while reducing overall industry costs.

Lumia Health is a digital health company enhancing quality of life for individuals with cardiovascular and neurological conditions, initially focusing on orthostatic syndromes. It achieves this through its in-ear wearable device and targeted software programs built upon continuous cardiac data.

Digbi Health specializes in digital therapeutics, offering personalized health programs for conditions like obesity, type 2 diabetes, gastrointestinal issues, and mental health. It uses precision biology, including genetics and gut microbiome analysis, to tailor care. The company provides an online platform tracking key metrics and offers virtual clinics prescribing GLP drugs.

Innsightful develops wearable devices that monitor and detect anxiety and stress symptoms using AI and machine learning. Their solution integrates biometrics for early detection and provides access to therapists for personalized recommendations, empowering users to understand and manage their mental health.

My Moves Matter offers a patient-centric digital platform designed to empower individuals living with Parkinson's disease. The platform provides tools for proactive self-management, including symptom tracking via a mobile app and personalized nutrition guidance tailored to Parkinson's care.

Manta Cares operates a global platform designed for cancer patients, caregivers, and survivors. It offers interactive maps, an engagement platform, planner, podcast, and newsletter to help navigate cancer treatment and recovery, fostering organization and information among the cancer community.

Local Infusion is an operator of an ambulatory infusion therapy center that specializes in delivering care for chronic autoimmune diseases. The company provides infusion therapies and qualified pharmaceuticals sourced from U.S. companies, focusing on enhancing patient outcomes while streamlining the treatment process for healthcare providers. By prioritizing affordability and efficiency, Local Infusion aims to facilitate appropriate treatment for patients, ultimately improving their overall healthcare experience.

Twill is a developer of a software-enabled healthcare platform focused on enhancing mental and physical wellness. The company offers a web and mobile-based technology that evaluates users' happiness through both subjective and objective assessments. In addition, Twill provides a variety of programs and games designed to promote healthier mindsets. This approach enables individuals, employers, and care delivery systems to effectively address issues such as stress, depression, anxiety, and social isolation, which are often associated with chronic illness. By integrating these tools, Twill aims to support users in achieving improved overall well-being.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Health Care Originals develops innovative solutions for managing chronic respiratory diseases. The company's flagship product is ADAMM, a three-part system consisting of a wearable device, smartphone application, and web portal. ADAMM monitors precursor symptoms of asthma attacks by tracking physiological characteristics such as cough counting, respiration, wheeze, and heart rate.

Health In Her HUE is a digital platform connecting Black women and women of color with culturally sensitive healthcare providers. It offers evidence-based health content tailored to these communities, aiming to reduce racial health disparities.

MiMARK focuses on developing in vitro diagnostic solutions for improved management of gynecological malignancies. Its primary objective is enhancing endometrial cancer diagnosis using advanced fluid-based testing.

Nivi is a digital health company that empowers individuals to make informed health decisions by providing on-demand, reliable, and actionable health information. It tracks and analyzes health journeys, from initial engagement with health content to seeking services or achieving health goals, enabling organizations in non-profit, commercial, and public sectors to tailor their services to better meet audience needs.

viO HealthTech develops a cycle monitoring platform focused on women’s reproductive health and menopause. The company addresses conception challenges and conditions such as polycystic ovary syndrome, diminished ovarian reserve, miscarriage risk, pregnancy complications, and menopausal issues by enabling comprehensive cycle tracking. Its system combines skin- and vaginal-temperature sensors with patient-reported events and artificial intelligence-based interpretation to predict and confirm ovulation, facilitate remote monitoring, and support screening and management of therapeutic interventions by clinicians. The platform provides a full-cycle view, integrating personal data to help women manage their cycles and identify potential fertility problems.

Nalagenetics is a health-tech company specializing in genetic testing aimed at improving healthcare outcomes. Established in 2016, the company partnered with the Indonesian health ministry to distribute genetic test kits in rural communities in Papua and West Papua. Their testing has uncovered significant genetic insights, such as identifying that 20% of leprosy patients in the region possess a gene linked to severe reactions to Dapsone, an important anti-leprosy medication. This discovery aids healthcare professionals in determining safe treatment options for affected patients. Nalagenetics also develops a personalized prescription platform that enhances prescription efficacy through genetic testing and information management, providing patients and healthcare decision-makers with tailored insights on interacting with healthcare technologies.

Founded in 2020, GPx is a Boston-based biotech company specializing in remote chronic disease management. It offers bloodless blood tests to transform the standard of care for cardiorenal diseases, empowering patients with better understanding of their condition.

The secure omics data infrastructure for the future of personalised medicine

Celero Systems is a life sciences company developing an ingestible system to detect and reverse opioid overdose. Its innovative technology monitors physiology from within the gastrointestinal tract, enabling timely interventions to reduce opioid overdose mortality and injury.

Citadel Discovery is a technology company specializing in artificial intelligence for drug discovery, diagnostics, and precision medicine. Its platform offers clients access to data, models, and results for biological exploration, enabling them to accelerate the development of therapeutics by exploring novel biology. The platform provides DNA-encoded libraries, computational methods across a wide range of disease-related proteins, and data generation, sharing, and analysis for rapid validation of predictive technologies.

nference is a technology company that develops AI-based software platforms for transforming biomedical knowledge. It synthesizes structured and unstructured data from various sources, offering real-time insights through neural networks. The company provides services in drug discovery, lifecycle management, and precision medicine.

Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.

Varient is a healthcare technology company focused on improving the treatment of rare genetic diseases through a patient-centric software application. The platform leverages artificial intelligence, genetics, and social listening data to collect patient-reported information on the effects of various medications. By analyzing this data, Varient aims to identify more effective treatments that have already shown positive results in specific patient groups. This approach not only aids individuals in finding the right therapies tailored to their genetic conditions but also serves as a decision support tool for healthcare providers and pharmaceutical companies. Ultimately, Varient seeks to accelerate the development of precision medicine, enhancing the overall efficiency of drug development in the rare disease sector.

Promptly is a health data analytics company that collects, integrates, and analyzes care outcome data. It develops proprietary technology for patient engagement, real-world data collection, and outcomes analytics to discover digital biomarkers. Promptly partners with healthcare organizations to improve patient care and reduce costs.

Umedeor Ltd is a technology company that specializes in data access for medical research and healthcare delivery. Established in 2017 and headquartered in London, with an additional office in New York, Umedeor develops a platform that automates the creation of prospective patient registries across a global network of healthcare providers. This innovative platform allows research organizations, healthcare providers, care agencies, and charities to efficiently monitor medical records and participate in multiple clinical programs simultaneously, without adding to their operational burden. By facilitating access to high-quality, compliant data, Umedeor supports life science companies in their research and development efforts, as well as post-market activities.

Scienta Lab is a biotechnology company that operates an AI-powered platform. This platform aims to develop patient-level autoimmune disease models, thereby transforming the drug discovery and development process in immunology and inflammation. The company's proprietary AI technology is designed to advance biotechnology for improved patient treatment in the healthcare sector.

Biostrap develops a wearable device for continuous biometric tracking, offering clinical-grade sensors that measure heart rate variability, respiratory rate, blood oxygen saturation, sleep metrics, and more. Its advanced analytics and remote monitoring capabilities enable healthcare providers and research institutions to deliver personalized health insights and improve patient outcomes.

Huma.AI provides an AI-powered knowledge automation platform for the healthcare and life sciences sectors. The platform connects disparate data silos by enabling natural-language queries to surface answers, insights, and actions from unstructured data such as documents and free text. By linking systems through human language, it helps researchers, clinicians, and organizations access data more quickly and make data-informed decisions. Huma.AI's solution is designed to improve efficiency in pharmaceutical and health care workflows by extracting insights from diverse data sources and presenting them in actionable form. The company was founded in 2016 and is based in Palo Alto, California.

Modus Health is a healthcare technology company that develops movement tracking solutions to provide accurate physical activity data and analytics for patients with slow or irregular gait. Its flagship StepWatch activity monitor measures daily activity to assess gait impairments, and Trex is an orthotics and prosthetics algorithm used to gauge functional levels in lower limb prosthesis users. The company serves academic and medical research institutions, orthotics and prosthetics providers, and neurorehabilitation applications, and offers online ordering of its solutions. Based in Washington, D.C., Modus Health focuses on enabling clinicians, researchers, and payors to make informed decisions by capturing actionable movement data that informs treatment and outcomes.

Deliberate AI specializes in multimodal artificial intelligence solutions aimed at enhancing mental health clinical trials and healthcare applications. The company focuses on three core areas: advanced diagnostics and monitoring, precision therapy enablement, and ambient clinical intelligence. By utilizing AI-based algorithms, Deliberate AI provides regulatory-grade objective measurement technology tailored for behavioral and mental health care. This platform equips clinicians, physicians, and healthcare researchers with critical data insights, enabling effective diagnostics and continuous monitoring for mental and neurological health challenges. Through its innovative approach, Deliberate AI aims to improve the quality of care and outcomes in mental health and clinical research.

Orbit Health specializes in developing artificial intelligence solutions for personalized treatment of Parkinson's disease.

Accexible is a technology company dedicated to developing a speech analysis platform that focuses on the early detection of mental health conditions. By utilizing artificial intelligence, Accexible has created a device capable of extracting acoustic characteristics from an individual's voice, which can reveal important insights into their health and well-being. The company specializes in identifying vocal biomarkers—specific features of voice that indicate various health conditions—facilitating the diagnosis and monitoring of diseases such as mild cognitive impairment and mild dementia. This innovative approach allows healthcare professionals to incorporate vocal analysis into care plans, enhancing their ability to detect and address mental health issues efficiently.

Vistim Labs is a MedTech diagnostic company focused on neurological disorders. It develops a noninvasive amyloid assessment and an AI-powered neurodiagnostic software that analyzes EEG data to identify brainwave patterns associated with the onset and progression of Alzheimer's disease and other dementias, helping clinicians diagnose and track disease progression.

WKD.SMRT is a company that specializes in enhancing healthcare research through a clinical trial data platform. By integrating advanced digital technologies such as sensing and machine learning, WKD.SMRT provides a means for collecting accurate real-world data from participants in their own homes. The platform facilitates remote interactions and utilizes innovative wireless sensor nodes, as well as wired and wearable technology, to capture a wide range of data, including motion, gesture, speech, text, emotion, physiology, and environmental factors. This approach not only ensures the privacy of participants but also aims to reduce inefficiencies and costs associated with traditional clinical trials, ultimately improving the quality and efficiency of healthcare research.

BeCareLink is a digital technology company focused on leveraging artificial intelligence to enhance clinical therapy for chronic neurodegenerative diseases. The company has developed an AI-based digital therapeutics platform that facilitates the prevention, prediction, and monitoring of conditions such as multiple sclerosis and fall risks in elderly patients. By providing quantifiable neurological assessments, BeCareLink enables patients to track their health-related activities and share this data with healthcare providers. The user-friendly applications are available on both Android and iOS, allowing for continuous health monitoring and potentially reducing treatment costs.

REACT Neuro is a Cambridge, Massachusetts-based company focused on improving brain health through an artificial intelligence-driven digital healthcare platform. The platform offers a range of services, including eye-tracking, voice recognition, and assessments of head and body movements, all through personalized virtual reality experiences. By utilizing scientifically validated exams, REACT Neuro quantifies brain health and develops digital biomarkers, specifically designed for multimodal neurophysiological phenotyping, which aids in understanding the aging brain's health. This approach enables patients to monitor their cognitive wellness objectively and supports informed decisions regarding healthy aging.

HealthQb is a health technology company that enables remote monitoring and management of biopsychosocial health. Its platform provides clinicians and other health providers with objective patient data gathered through wearables and a patient application, supporting triage and care decisions that help individuals reach their health goals. The system tracks biopsychosocial metrics via wearable devices and a healthcare portal to support remote monitoring and behavior change guidance, targeting patients with chronic illnesses. By identifying root causes of health behaviors and offering ongoing coaching and feedback, HealthQb aims to sustain healthy behaviors and improve long-term outcomes across care settings such as rehabilitation, physiotherapy, and primary care.

Neuroventis is a digital healthcare company focused on neurology, offering a CE-marked medical device that facilitates the management and registration of neurological disorders. The Neuroventis platform allows patients to track their health data and share it with their medical teams, thereby enhancing communication and collaboration. By improving the interaction between patients and healthcare professionals, Neuroventis empowers individuals to take a more active role in their health management, fostering stronger partnerships in the clinical setting. The company's mission is to elevate the standard of care in neurology and support patients in confidently navigating their health challenges.

Head Diagnostics is a life sciences technology company developing digital neurotechnology for advancing brain health diagnostics and monitoring. Its key products include iTremor One, a device measuring oscillatory movement traits as a neurophysiological brain biomarker, and HDx Cognition, a cognitive assessment tool.

Nori Health is a healthcare platform designed to offer personalized support for individuals living with chronic diseases, particularly those with inflammatory bowel disease. The company features a chatbot coach that engages in regular conversations with users to help identify and modify lifestyle factors contributing to their health issues. By promoting lifestyle changes, Nori Health aims to enhance the quality of life for patients, alleviating symptoms such as fatigue, pain, and anxiety. Through its innovative approach, Nori Health seeks to empower individuals to take control of their health and improve their overall well-being.

Droice Labs develops AI-powered middleware software, Droice Hawk, which processes messy, noisy real-world patient data from various sources like EMRs, labs, claims, and free text. It generates analysis-ready data for novel clinical and research use cases.

Longenesis operates a blockchain-based marketplace for personal data. It converts health data into tokens, ensuring secure storage and privacy while facilitating transactions between users and pharmaceutical businesses.

SmartTab is a pharmaceutical company developing wireless drug delivery and monitoring technologies. Its platform centers on an ingestible capsule equipped with an electronic receiver and actuator to enable targeted medication delivery and real-time monitoring. The company aims to improve patient outcomes and treatment adherence through platforms such as TargetTab, InjectTab, and MultiTab, leveraging inductive power and Internet of Medical Things integration to optimize therapy. Founded in 2015 and based in Denver, Colorado, SmartTab focuses on creating low-toxicity delivery systems and data-enabled therapy management.

The Clinician Ltd is a health IT company based in Auckland, New Zealand, with an additional office in Singapore. Established in 2015, it specializes in enhancing patient engagement and care outcomes through its flagship product, ZeDoc, a cloud-based platform designed for patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). The platform facilitates the distribution, collection, and analysis of PROMs data throughout the patient care continuum, integrating seamlessly into existing clinical workflows. Utilizing artificial intelligence-driven chatbots and data science techniques, ZeDoc minimizes the burden of patient questionnaires and enables real-time monitoring of patient feedback. This innovative approach allows healthcare providers to assess patient cohorts, identify at-risk cases, and implement necessary interventions, ultimately supporting a patient-centric value-based care model. The Clinician is recognized as a first mover in the Asia Pacific region, with a management team possessing extensive experience across medicine, engineering, research, and business intelligence.

Seascape Clinical specializes in streamlining clinical trial management. Its cloud-based platform integrates data from diverse sources, generating real-time dashboards and trackers to support informed decision-making by clinical operations teams. This automation and consolidation of data aims to optimize clinical trial oversight and accelerate drug development for its clients.

Neuroute is an AI-driven platform designed to streamline clinical trial patient recruitment. It employs artificial intelligence to create targeted recruitment strategies and campaigns, connecting healthcare professionals with patients more efficiently.

Prism helps life science teams organize their documents, unlock new insights, and efficiently communicate with our intuitive, highly-configurable knowledge management software.

Tag.bio is a healthcare information technology company based in San Francisco. It develops a data science platform that enables healthcare and life sciences organizations to securely derive insights by uniting diverse siloed datasets into data products within a data mesh architecture. The platform supports no-code and low-code workflows, allowing users to discover, share, and execute data workloads through applications and AI-enabled solutions. It combines datasets, smart APIs, and statistical and machine learning algorithms into data products, enabling users to derive actionable insights through apps while offering deployment options in AWS and Azure marketplaces.

Liyfe is a healthcare technology company that operates a remote symptom management platform designed to automate nurse triage pathways for oncology patients and those at risk for non-alcoholic steatohepatitis (NASH). The platform focuses on educating patients about managing their symptoms at home, while also providing tools for monitoring and assessing their nutritional and emotional needs. Through evidence-based and standardized protocols, Liyfe enables patients to report their symptoms and submit queries, facilitating proactive management of their health. This innovative approach aims to enhance patient engagement and improve outcomes in high-risk populations.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, is a digital therapeutics company focused on transforming the management of neurocognitive and neuromotor disorders. The company has developed an artificial intelligence tool called neuroQWERTY that facilitates early detection and remote monitoring of diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. By passively collecting data from users' interactions with everyday electronic devices, nQ Medical captures subtle changes in motor function and cognitive abilities that may indicate disease progression. This innovative approach allows for continuous, non-invasive monitoring without requiring specific tasks from users, making it a cost-effective alternative to traditional diagnostic methods. The platform not only diagnoses conditions but also tracks therapeutic effectiveness, enabling better communication between clinicians and patients. By focusing on early detection and reliable disease progression markers, nQ Medical aims to enhance the management of neurological disorders and prepare for the future introduction of disease-modifying therapies.

EVOCAL Health is a digital diagnostics company focused on the early detection of diseases through the analysis of vocal biomarkers. By utilizing advanced healthcare intelligence algorithms powered by artificial intelligence and machine learning, the company aims to leverage voice, breathing, and coughing sounds to identify health issues. This innovative approach seeks to transform disease detection and treatment by offering a more accurate, rapid, and cost-effective alternative to traditional methods. EVOCAL Health envisions using everyday technologies, such as smartphones, to enable widespread access to its diagnostic capabilities, making it possible for individuals around the globe to monitor their health and receive timely diagnoses, thereby promoting longer and healthier lives.